Aquatic Animal Gene Overexpression Service

BioVenic provides customized pipelines of expression construct synthesis, transcript preparation and digital validation for fish, crustaceans and mollusks to achieve reliable in vivo transcript upregulation. As a core methodology in aquaculture research, in vivo amplification of specific transcript abundance helps decode genomic architecture and explore gene functional networks. By elevating target gene expression, this approach enables researchers to identify cryptic developmental roles, trace organogenesis pathways and establish accurate disease models, supporting advances in aquaculture biotechnology.

Inaugural Research Endeavors We Accelerate

• Academic laboratories analyzing fundamental embryonic patterning, transcriptional cascades, and gene regulatory networks during early ontogeny.
• Aquaculture breeding groups assessing the metabolic consequences of growth promoting transcripts, nutrient utilization regulators, and stress tolerance factors.
• Translational drug discovery groups establishing robust genetic disease models through the continuous overexpression of specific clinical variants.

Fig 1. Strategies to control oncogene expression in zebrafish cancer models.¹

Navigating Key Biological and Technical Bottlenecks

• Instability of administered transcripts: Maximizing messenger RNA half life in embryonic environments using customized structural modifications including chemical capping and tailing.
• Position effect variegation and silencing: Deploying active transposable cassettes to achieve clean, single copy genomic insertion without introducing foreign plasmid backbones.
• Systemic ectopic expression toxicity: Restricting transcription to specified developmental windows or localized cellular structures via custom promoters.
• Intractable delivery barriers in non-model hosts: Customizing microinjection pressure parameters and buffer salinity to safely penetrate thick chorions or yolk rich zygotes.

Comprehensive Aquatic Gene Overexpression Services

• Transient Transcript Amplification via Messenger RNA Delivery

Applicable Scenarios: Selected for immediate gain of function assays, fast screening of candidate phenotypic regulators, and analysis of early embryonic development.

Technical Capabilities: We clone target open reading frames into high efficiency transcription vectors, followed by in vitro enzymatic synthesis. Transcripts undergo rigorous polyadenylation and capping to ensure superior translational activity upon introduction.

Deliverables: High resolution transcript purity chromatograms, concentration profiling data, validation dossiers documenting translation kinetics, and quantitative expression datasets.

• Heritable Expression Cassette Integration

Applicable Scenarios: Required for generational inheritance studies, lineage mapping, and evaluating the long-term physiological effects of elevated gene dosage.

Technical Capabilities: Utilizing active transposition systems such as Tol2 or Sleeping Beauty, we engineer custom donor vectors that achieve high efficiency germline integration and predictable transgene transmission.

Deliverables: Verified plasmid maps, digital copy number profiling assays, genomic junction sequencing datasets, and F1 generation segregation profiles.

• Regulated Spatial and Conditional Expression Systems

Applicable Scenarios: Vital for escaping early embryonic lethality or restricting elevated transcription to specific systems like cardiac, hepatic, or muscular tissues.

Technical Capabilities: We assemble transcription units driven by well characterized tissue specific promoters or chemically inducible elements that respond directly to non-toxic small molecules or thermal shifts.

Deliverables: Plasmid construct verification reports, spatial profiling dossiers, and high resolution digital imaging datasets confirming localized target expression.

Chronological Framework from Design to Digital Validation

Our production pipeline is designed to maximize embryo viability, optimize transcription amplitude, and provide exhaustive digital validation datasets.

1. Vector Engineering and Assembly: Cloning the target gene sequence into customized expression vectors equipped with strong promoters, translation enhancers, and selection markers.
2. In Vitro Transcription and Synthesis: Performing high fidelity plasmid amplification or in vitro transcription to produce highly concentrated, ultrapure injection materials.
3. Precision Embryo Injection: Administering the synthesized transcripts or transposable plasmids directly into early stage embryos using species optimized microinjection parameters.
4. Quantitative Expression Profiling: Verifying successful target upregulation at key developmental stages utilizing quantitative polymerase chain reaction, transcript sequencing, and Western blotting.
5. Phenotypic Profiling and Functional Analysis: Evaluating the biological consequences of gene overexpression through detailed optical clearing, fluorescent microscopy, and initial physiological profiling.
6. Validation Dossier Delivery: Delivery of the complete project documentation containing digital sequence files, alignment data, quantitative expression profiles, and ready to publish protocols.

Unique Strengths of Our Genomic Platforms

• Advanced chromatin engineering: Utilizing insulated boundary sequences to protect stable expression cassettes from epigenetic silencing by neighboring chromatin.
• Unrivaled species expertise: Customized microinjection and culture setups validated for salmonids, medaka, zebrafish, marine shrimp, and bivalve shellfish.
• Multilayered molecular verification: Combining digital droplet PCR copy number assays with high throughput sequencing to guarantee sequence fidelity and precise integration.
• Complete downstream evaluation: Supporting project teams with advanced optical tissue clearing, confocal digital imaging, and multi omics profiling datasets.

Downstream Explorations Driven by Elevated Expression

• Functional gene annotation

Defining the biological pathways and physical interactions of newly sequenced or uncharacterized open reading frames in vivo.

• Selection marker validation

Overexpressing key metabolic or immune regulatory genes to identify performance indicators for selective breeding programs.

• Human pathology replication

Overexpressing conserved disease variants in model organisms to evaluate drug candidates and pathogenic mechanisms.

• Cellular lineage mapping

Generating stable fluorescent reporter models to observe migration pathways and cellular differentiation in real time.

Frequently Asked Questions

1. How do you select the optimal promoter to achieve robust gene overexpression in non-model aquatic species?
   We evaluate endogenous sequence database profiles using in silico alignments. If characterized, species specific promoters are unavailable in the literature, we utilize robust, broad range promoters or custom design chimeric promoter cassettes. This step ensures high transcriptional activity and robust translation within the target host tissues.
2. How do you ensure stable, non-silencing transgene expression over multiple generations?
   Rather than using random integration vectors which often cause concatemer formation and rapid epigenetic silencing, we deploy active transposable elements like Tol2. These tools integrate clean, single copy expression cassettes into the host genome. We also flank our constructs with chromatin insulator elements to shield the transgene from adjacent heterochromatin silencing.
3. What analytical assays are used to quantitatively verify successful target transcript and protein upregulation?
   We do not rely solely on phenotypic observations. Our digital validation packages include quantitative polymerase chain reaction assays to measure transcript abundance, Western blot protein quantification assays, and spatial profiling using high resolution fluorescent microscopy to verify appropriate cellular expression and localization.

Partner with BioVenic

BioVenic is committed to boosting innovative research in aquatic biology and modern aquaculture through reliable aquatic animal gene overexpression services. We understand that targeted gene overexpression is essential for exploring gene functions, regulating biological processes and optimizing aquatic breeding characteristics. Our professional technical team delivers mature and customized experimental solutions to support your academic and industrial research. To discuss your specific project requirements, explore our technical capabilities, or receive a detailed quote for your study, please contact us. Our experts are ready to drive your aquatic research toward valuable new breakthroughs.

Our products and services are for research use only and cannot be used for any clinical purposes.

Related Services